Memantine
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Memantine and local guidelines before prescribing.
NMDA antagonist
Mechanism
NMDA receptor antagonist.
Uses
Moderate to severe Alzheimer disease.
Dosing
- Memantine 5 mg, up to 20 mg daily | Moderate AD if AChEI unsuitable; severe AD; add-on; reduce to 10 mg if CrCl under 30 mL/min.
Neurology: Dementia and Cognition Disorders (Complete)
Side effects
Dizziness, headache, constipation, hypertension, confusion.
Interactions
Other NMDA antagonists (amantadine, ketamine, dextromethorphan).
Contraindications and cautions
Epilepsy, severe renal impairment
Monitoring
Blood pressure, confusion
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose if CrCl below 50
Overdose and reversal
Supportive
Special advice
Titrate slowly; reduce dose in renal impairment; caution in epilepsy.
More from the textbook: uses, cautions and other points
- Glutamate | Main excitatory transmitter; learning and memory (NMDA and AMPA receptors) | Excitotoxic cell death in stroke and trauma; memantine and ketamine block NMDA; perampanel blocks AMPA; riluzole reduces release (MND)
Neurology: Anatomy, Physiology and Pharmacology - Memantine - NMDA receptor antagonist ; moderate to severe Alzheimer's (alone, or added to an AChE inhibitor); dizziness, headache, constipation, drowsiness; reduce dose in CKD.
Neurology: Anatomy, Physiology and Pharmacology - Memantine if these are not tolerated.
Neurology: Movement Disorders - Oscillopsia (shaky vision from nystagmus): Gabapentin or memantine.
Neurology: Multiple Sclerosis and inflammatory disease - AChEIs and memantine are not recommended for pure vascular dementia - offer them only if Alzheimer's disease, DLB or PDD is suspected to coexist ( mixed dementia ).
Neurology: Dementia and Cognition Disorders (Complete) - AChEIs - donepezil or rivastigmine (NICE) - often help cognition, fluctuations and hallucinations. Galantamine if these aren't tolerated; memantine if AChEIs are unsuitable.
Neurology: Dementia and Cognition Disorders (Complete)
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (3 mentions)
- Neurology: Movement Disorders (1 mention)
- Neurology: Multiple Sclerosis and inflammatory disease (1 mention)
- Neurology: Dementia and Cognition Disorders (Complete) (5 mentions)
- Medicine of the older adult: Delirium, dementia and mood in older people (5 mentions)
- Physiology: Nerve, muscle and autonomic systems, exercise, pregnancy and ageing (2 mentions)